Saturday, October 15, 2022 from 1:45 PM to 3:15 PM PDT at Continental Ballrooms 7-9
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-22-151-L02-P
Activity Type: A Knowledge-Based Activity
This session focuses on the prevention of new HIV infections. Specific topics will include: (1) access and persistence to HIV prevention medication and services, (2) the HIV prevention pipeline, and (3) best practices for pharmacist driven HIV prevention services (testing, prescribing, harm reduction; including legislative considerations). This session will provide the opportunity to increase knowledge of HIV prevention methods and encourage pharmacists to incorporate HIV prevention services into their practice sites.
 | Moderator: Marisa Brizzi, Pharm.D., BCPS, AAHIVP
Clinical Pharmacy Specialist - Pain Stewardship and HIV
UC Health in Cincinnati, OH
View Biography |
Learning Objectives
1. Discuss how social determinates of health and racial/ethnic disparities lead to health inequity in HIV PrEP.
2. Evaluate strategies for improving the HIV PrEP care continuum across care settings.
3. Identify solutions to potential drug related problems with long-acting cabotegravir, including PK/PD challenges.
4. Describe how novel agents for HIV PrEP in the pipeline could help overcome current challenges.
5. Outline opportunities for pharmacists to provide HIV PEP and PrEP services.
6. Illustrate potential strategies for pharmacist involvement in HIV screening and harm reduction initiatives.